West Pharmaceutical Services
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $805,000 | $804,300 | $766,200 | $698,200 |
Gross Profit | 303,900 | 293,500 | 273,200 | 232,700 |
EBITDA | 209,500 | 217,100 | 198,500 | 150,900 |
EBIT | 162,500 | 174,100 | 157,100 | 110,900 |
Net Income | 132,100 | 140,000 | 131,800 | 89,800 |
Net Change In Cash | 805,000 | 804,300 | 766,200 | 698,200 |
Free Cash Flow | 175,000 | 133,900 | 101,900 | 58,100 |
Cash | 791,300 | 628,500 | 509,700 | 404,200 |
Basic Shares | 72,700 | 72,700 | 72,800 | 73,000 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,073,700 | $2,892,700 | $2,951,100 | $2,885,500 |
Gross Profit | 1,103,300 | 1,002,200 | 1,132,700 | 1,138,900 |
EBITDA | 723,600 | 743,800 | 844,100 | 808,100 |
EBIT | 599,200 | 588,400 | 706,800 | 687,500 |
Net Income | 493,700 | 492,700 | 593,400 | 585,900 |
Net Change In Cash | 3,073,700 | 2,892,700 | 2,951,100 | 2,885,500 |
Cost of Revenue | 142,200 | |||
Free Cash Flow | 468,900 | 276,400 | 414,500 | 439,400 |
Cash | 791,300 | 484,600 | 853,900 | 894,300 |
Basic Shares | 72,700 | 73,700 | 75,300 | 75,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $2.04 |
2025-09-30 | $1.96 |
2025-06-30 | $1.84 |
2025-03-31 | $1.45 |